| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.037 | 0.4 |